Pancreatic cancer

Disease-a-Month

Volumn 50, Issue 10, 2004, Pages 545-555

  Brand, Randall ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; GEMCITABINE; INTERFERON;

CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CANCER STAGING; CANCER SURGERY; CIGARETTE SMOKING; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; GENETIC RISK; HIGH RISK POPULATION; HUMAN; LAPAROSCOPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CANCER; PATHOPHYSIOLOGY; REVIEW;

EID: 10444250180     PISSN: 00115029     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.disamonth.2004.09.001     Document Type: Article

References (56)

1. Cancer Facts & Figures 2004 2004 American Cancer Society Atlanta
2. J. Ferlay, F. Bray, P. Pisani Globocan 2000: Cancer Incidence, Mortality and Prevalence Worldwide, Version 1.0. IARC Cancer Base No. 5 2001 Lyons IARC Press
3. K.D. Lillemoe, C.J. Yeo, J.L. Cameron Pancreatic cancer State-of-the-art care CA Cancer J Clin 50 4 2000 241 268
4. P. Ghadirian, H.T. Lynch, D. Krewski Epidemiology of pancreatic cancer An overview Cancer Detect Prev 27 2 2003 87 93
5. C.S. Fuchs, G.A. Colditz, M.J. Stamper A prospective study of cigarette smoking and the risk of pancreatic cancer Arch Intern Med 156 19 1996 2255 2260
6. E.B. Gold, S.B. Goldin Epidemiology of and risk factors for pancreatic cancer Surg Oncol Clin N Am 7 1998 67 91
7. I.D. Norton, B.T. Petersen, I.J. Millr Frequency of a family history of pancreatic malignancy in patients with pancreatic malignancy Pancreas 17 1998 451
8. R.E. Brand, H.T. Lynch Hereditary pancreatic adenocarcinoma A clinical perspective D.C. Whitcomb J.A. Cohn C.D. Ulrich The Medical Clinics of North America Inherited Diseases of the Pancreas 84 2000 W.B. Saunders Co Philadelphia (PA) 665 675
9. A.B. Lowenfels, P. Maisonneuve, E.P. DiMagno Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group J Natl Cancer Inst 89 6 1997 442 446
10. M.S. Brose, T.R. Rebbeck, K.A. Calzone Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program J Natl Cancer Inst 94 18 2002 1365 1372
11. Cancer risks in BRCA2 mutation carriers The Breast Cancer Linkage Consortium J Natl Cancer Inst 91 15 1999 1310 1316
12. A.M. Goldstein, M.C. Fraser, J.P. Struewing Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations N Engl J Med 333 15 1995 970 974
13. G.H. Su, R.H. Hruban, R.K. Bansal Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers Am J Pathol 154 6 1999 1835 1840
14. A.P. Klein, K.A. Brune, G.M. Petersen Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds Cancer Res 64 7 2004 2634 2638
15. A.B. Lowenfels, P. Maisonneuve, G. Cavallini Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group N Engl J Med 328 20 1993 1433 1437
16. D. Malka, P. Hammel, F. Maire Risk of pancreatic adenocarcinoma in chronic pancreatitis Gut 51 6 2002 849 852
17. R.Z. Stolzenberg-Solomon, M.J. Blaser, P.J. Limburg Helicobacter pylori seropositivity as a risk factor for pancreatic cancer J Natl Cancer Inst 93 12 2001 937 941
18. P. Maisonneuve, S.C. FitzSimmons, J.P. Neglia Cancer risk in nontransplanted and transplanted cystic fibrosis patients A 10-year study J Natl Cancer Inst 95 5 2003 381 387
19. A.B. Lowenfels, P. Maisonneuve, D.C. Whitcomb Risk factors for cancer in hereditary pancreatitis D.C. Whitcomb J.A. Cohn C.D. Ulrich The Medical Clinics of North America Inherited Diseases of the Pancreas 84 2000 W.B. Saunders Co Philadelphia (PA) 565 573 3
20. S.J. Rulyak, A.B. Lowenfels, P. Maisonneuve Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds Gastroenterology 124 5 2003 1292 1299
21. D.S. Michaud, E. Giovannucci, W.C. Willet Physical activity, obesity, height, and the risk of pancreatic cancer Jama 286 8 2001 921 929
22. D. Li, X. Keping, R. Wolff Pancreatic cancer Lancet 363 9414 2004 1049 1057
23. R.H. Hruban, M. Goggins, J. Parsons Progression model for pancreatic cancer Clin Cancer Res 6 8 2000 2969 2972
24. R.W. Parks, O.J. Garden Ensuring early diagnosis in pancreatic cancer Practitioner 244 1609 2000 336 343
25. J.S. Barkin, J.A. Goldstein Diagnostic and therapeutic approach to pancreatic cancer Biomed Pharmacother 54 7 2000 400 409
26. E.P. DiMagno Pancreatic cancer Clinical presentation, pitfalls, and early clues Ann Oncol 10 Suppl 4 1999 140 142
27. E.P. DiMagno, J.R. Malagelada, W.P. Taylor A prospective comparison of current diagnostic tests for pancreatic cancer N Engl J Med 97 14 1977 737 742
28. R.L. Krech, D. Walsh Symptoms of pancreatic cancer J Pain Symptom Manage 6 6 1991 360 367
29. E.A. Holly, I. Chaliha, P.M. Bracci Signs and symptoms of pancreatic cancer A population-based case-control study in the San Francisco Bay area Clin Gastroenterol Hepatol 2 6 2004 510 517
30. S. Sugiyama, M. Asada, R. Fujita Endoscopic ultrasonography for the diagnosis of pancreatic carcinoma Endoscopy 20 1988 94
31. S.J. Hessel, S.S. Siegelman, B.J. McNeil Pancreatic adenocarcinoma diagnosis and staging with CT and complementary imaging Radiology 143 1988 129 133
32. D.A. Bluemke, J.L. Cameron, R.H. Hruban Potentially resectable pancreatic adenocarcinoma Spiral CT assessment with surgical and pathologic correlation Radiology 197 2 1995 381 385
33. A. Soriano, A. Castells, C. Ayusa Preoperative staging and tumor resectability assessment of pancreatic cancer Prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging, and angiography Am J Gastroenterol 99 3 2004 492 501
34. C. Valls, E. Andia, A. Sanchez Dual-phase helical CT of pancreatic adenocarcinoma Assessment of resectability before surgery AJR Am J Roentgenol 178 4 2002 821 826
35. M.G. House, C.J. Yeo, J.L. Cameron Predicting resectability of periampullary cancer with three-dimensional computed tomography J Gastrointest Surg 8 3 2004 280 288
36. M.F. Muller, C. Meyenberger, P. Bertschinger Pancreatic tumors evaluation with endoscopic US, CT, and MR imaging Radiology 190 3 1994 745 751
37. A.D. Vellet, W. Romano, D.B. Bach Adenocarcinoma of the pancreatic ducts Comparative evaluation with CT and MR imaging at 1.5 T Radiology 183 1 1992 87 95
38. W. Schima, R. Fugger, E. Schober Diagnosis and staging of pancreatic cancer Comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro-CT AJR Am J Roentgenol 179 3 2002 717 724
39. H.E. Lopez, H. Amthauer, N. Hosten Prospective evaluation of pancreatic tumors Accuracy of MR imaging with MR cholangiopancreatography and MR angiography Radiology 224 1 2002 34 41
40. K. Yasuda, H. Mukai, M. Nakajima Endoscopic ultrasonography diagnosis of pancreatic cancer Gastrointest Endosc Clin N Am 5 4 1995 699 712
41. T. Rosch Diagnosis and staging of pancreatic cancer by EUS A critical analysis, in 10th Int Symp on Endoscopic Ultrasonography, Cleveland 1995 153 162
42. P. Vilmann, G.K. Jacobsen, F.W. Henriksen Endoscopic ultrasonography with guided fine needle aspiration biopsy in pancreatic disease Gastrointest Endosc 38 2 1992 172 173
43. K.J. Chang Endoscopic ultrasound-guided fine needle aspiration in the diagnosis and staging of pancreatic tumors Gastrointest Endosc Clin N Am 5 4 1995 723 734
44. F. Gress, K. Gottlieb, S. Sherman Endoscopic ultrasonography-guided fine-needle aspiration biopsy of suspected pancreatic cancer Ann Intern Med 134 6 2001 459 464
45. M.I. Canto, M. Goggins, C.J. Yeo Screening for pancreatic neoplasia in high-risk individuals An EUS-based approach Clin Gastroenterol Hepatol 2 7 2004 606 621
46. M.M. Murr, M.G. Sarr, A.J. Oishi Pancreatic cancer CA Cancer J Clin 44 5 1994 304 318
47. C. Niederau, J.H. Grendell Diagnosis of pancreatic carcinoma. Imaging techniques and tumor markers Pancreas 7 1 1992 66 86
48. G. Aliperti Complications related to diagnostic and therapeutic endoscopic retrograde cholangiopancreatography Gastrointest Endosc Clin N Am 6 2 1996 379 407
49. R.A. Kozarek Endoscopy in the management of malignant obstructive jaundice Gastrointest Endosc Clin N Am 6 1 1996 153 176
50. Y. Kubota, M. Takaoka, K. Tain Endoscopic transpapillary biopsy for diagnosis of patients with pancreaticobiliary ductal strictures Am J Gastroenterol 88 10 1993 1700 1704
51. A.P. Ferrari, D.R. Lichtenstein, A. Slivka Brush cytology during ERCP for the diagnosis of biliary and pancreatic malignancies Gastrointest Endosc 40 1994 140 145
52. M.D. Lieberman, H. Kilburn, M. Lindsey Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy Ann Surg 222 5 1995 638 645
53. V.J. Picozzi, R.A. Kozarek, L.W. Traverso Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma Am J Surg 185 5 2003 476 480
54. J.P. Neoptolemos, D.D. Stocken, H. Friess A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer N Engl J Med 350 12 2004 1200 1210
55. M. Tempero Randomized phase II comparison of dose-intense gemcitabine Thirty-minute infusion and fixed dose rate infusion in patients with pancreatic adenocarcinoma J Clin Oncol 21 18 2003 3402 3408
56. P.K. Mills, W.L. Beeson, D.E. Abbey Dietary habits and past medical history as related to fatal pancreas cancer risk among Adventists Cancer 61 12 1988 2578 2585